Glucose Biosensor Market Synopsis:
Glucose Biosensor Market Size Was Valued at USD 12.11 Billion in 2023, and is Projected to Reach USD 23.21 Billion by 2032, Growing at a CAGR of 7.5% From 2024-2032.
The glucose biosensor market can be defined as products that are aimed at recognizing glucose amounts in the human body, with a focus on diabetic patients. Some of these biosensors employ electrochemical, optical, or thermal-based approaches to offer real time glucose report to the interests of patients to have efficient control over the level of blood sugar. For some of the biosensors, the increasing rate of diabetes and the need for continuous glucose monitoring systems contribute to the market growth and development and consequently influencing the biosensors technology.
The main trend that furthers the glucose biosensor growth is the growth rate of people diagnosed with diabetes all over the globe. As over millions of people are diagnosed with diabetes every year, the demand for efficient and easy-to-use monitoring tools arises. Lifestyle diseases, together with a growing global population with increasing life expectancy, has created an increased need for glucose biosensors. Also, increasing focus towards home healthcare and self-monitoring blood glucose (SMBG) to develop easy to use solutions has been the key drivers for this market.
The second factor is the enhancement in biosensor technologies. Technological advancements like advancement of glucose monitoring gloves and multiple-site testing methods, enhanced electrochemical sensors and limited invasive glucose meter measurement have contributed towards making a qualitative measure of glucose. In addition, there is the inclusion of biosensors into clients’ Pam management touch points such as mobile apps, and cloud computing has improved client interaction and record keeping. It not only increases the performance of the devices in measuring the level of glucose, but also share helpful information concerning our health status, which motivates the consumers and fuels the market as well.
Glucose Biosensor Market Trend Analysis:
The shift towards non-invasive monitoring technologies.
-
Non-invasive monitoring is another trend that is emerging in the glucose biosensor industry. Other traditional invasive are known to need blood samples though which could be uncomfortable to the users. In response, researchers and manufacturers are striving to research and come up with nonhostile biosensors that capture methods such as Infrared spectroscopy and transdermal sensors. Considering this tendency, people’s blood glucose levels will be controlled more comfortable and convenient, especially for patients with diabetes who have to take glucose tests frequently.
- The second emerging trend of interest is the increased design of glucose biosensors with linkages to mobile health and digital health platforms. However, in the present generation, most biosensors are developed to be connected to other devices such as smartphones through Bluetooth hence providing real-time results. This integration enhances the capacity of users to monitor their glucose levels, analyse trends and share this information with the healthcare givers. Subsequently, it enhances the patients’ conditions and helps the proper ways of diabetes management.
The expansion of product offerings for diverse patient populations.
-
One of the most potential unmet needs in the glucose biosensor market is the ability to extend the portfolio for patients with multiple diseases or complications. Increasingly niche areas within diabetes care, including children with type 1, and the elderly type 2 diabetics, have created a need for targeted biosensors. In responding to these results, companies are encouraged to concentrate on creating simple to use, well designed, and highly accurate biosensing devices to fill this niche market and obtain a wider share of the market.
- Third, glucose biosensors have a high level of growth potential in emerging markets as well for its manufacturers. As the facility in the healthcare sector rises in Asian, African, and Latin American countries, an opportunity for demand for proper diabetes management will also rise. By reaching these areas through partnerships, local production or advertising and promoting products that can assist in monitoring diabetes, companies can expect to reap the benefits arising from rising prevalence of the disease.
Glucose Biosensor Market Segment Analysis:
Glucose Biosensor Market is Segmented on the basis of Product type, Technology, Application, End User, and Region
By Product Type, Invasive Glucose Biosensors segment is expected to dominate the market during the forecast period
-
The glucose biosensor market has been classified under the invasive and non-invasive product types that are used in the monitoring of glucose. Currently available invasive glucose biosensors need a sample of blood which is mostly taken through pricking of a finger to give appropriate glucose levels. Such devices are applied in a conventional multidisciplinary diabetes management approach to provide accurate measurements. On the other hand, the invasive glucose biosensors work with new technologies to estimate the glucose level without involving blood sample. These include the infrared spectroscopy, trans dermal sensor as well as other optical applications. The non-invasive biosensors are preferred by many patients due to the discomfort and pain that comes with blood sampling making the development such biosensors favourable for convenient monitoring.
By Application, Diabetes Management segment expected to held the largest share
-
The glucose biosensor market is segmented on the basis of its application in few major areas such as diabetes management, clinical diagnostics, drug development and others. The most important use is the diabetes one since glucose biosensors are used to help the people in controlling the levels of sugar in their blood, hence decreasing the effects of the relevant condition. Another important application in real life is clinical diagnostics in which glucose biosensors are used in healthcare settings, for diagnosing various metabolic disorders for which appropriate action can be taken by doctors. In the development of drugs, these biosensors are used to support researchers in the determination of pharmacokinetic and able parameters of new drugs with reference to regulated glucose. Other application may include nutritional research, fitness tracking, and general metabolism indicating the increasing role and applicability of glucose biosensors in real world.
Glucose Biosensor Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America continues to enjoy the largest supply of glucose biosensors following advancements in healthcare and increased incidences of the disease. It is inhabited by a population that has had access to care more than any other part of the world, and there is a trend towards more preventive measures to control glucose levels which translates to higher use of monitoring devices. In addition, the existence of important market participants and continuing research and development processes also facilitate the North American market.
- The other reason is the encouraging reimbursement policies in North America that helps patients to afford diabetes management devices. Also, through CGM systems, consumers in this region are shifting their focus towards technological improvement, which in return supports the market. Altogether, these factors have setup North America as the dominant region in the glucose biosensor market.
Active Key Players in the Glucose Biosensor Market:
-
Abbott Laboratories (United States)
- Roche Diagnostics (Switzerland)
- Dexcom, Inc. (United States)
- Medtronic plc (Ireland)
- Johnson & Johnson (United States)
- Siemens Healthineers (Germany)
- Lifescan, Inc. (United States)
- Ascensia Diabetes Care (Switzerland)
- A. Menarini Diagnostics (Italy)
- GlucoRx (United Kingdom)
- Other Active Players
|
Global Glucose Biosensor Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 12.11 Billion |
|
Forecast Period 2024-32 CAGR: |
7.50 % |
Market Size in 2032: |
USD 23.21 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
Technology |
|
||
|
By Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Glucose Biosensor Market by Product Type
4.1 Glucose Biosensor Market Snapshot and Growth Engine
4.2 Glucose Biosensor Market Overview
4.3 Invasive Glucose Biosensors
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Invasive Glucose Biosensors: Geographic Segmentation Analysis
4.4 Non-invasive Glucose Biosensors
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Non-invasive Glucose Biosensors: Geographic Segmentation Analysis
Chapter 5: Glucose Biosensor Market by Technology
5.1 Glucose Biosensor Market Snapshot and Growth Engine
5.2 Glucose Biosensor Market Overview
5.3 Electrochemical Biosensors
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Electrochemical Biosensors: Geographic Segmentation Analysis
5.4 Optical Biosensors
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Optical Biosensors: Geographic Segmentation Analysis
5.5 Thermal Biosensors
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Thermal Biosensors: Geographic Segmentation Analysis
Chapter 6: Glucose Biosensor Market by Application
6.1 Glucose Biosensor Market Snapshot and Growth Engine
6.2 Glucose Biosensor Market Overview
6.3 Diabetes Management
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Diabetes Management: Geographic Segmentation Analysis
6.4 Clinical Diagnostics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinical Diagnostics: Geographic Segmentation Analysis
6.5 Drug Development
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Drug Development: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Glucose Biosensor Market by End User
7.1 Glucose Biosensor Market Snapshot and Growth Engine
7.2 Glucose Biosensor Market Overview
7.3 Hospitals and Clinics
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals and Clinics: Geographic Segmentation Analysis
7.4 Homecare
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Homecare: Geographic Segmentation Analysis
7.5 Research Laboratories
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Research Laboratories: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Glucose Biosensor Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ABBOTT LABORATORIES (UNITED STATES)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ROCHE DIAGNOSTICS (SWITZERLAND)
8.4 DEXCOM INC. (UNITED STATES)
8.5 MEDTRONIC PLC (IRELAND)
8.6 JOHNSON & JOHNSON (UNITED STATES)
8.7 SIEMENS HEALTHINEERS (GERMANY)
8.8 LIFESCAN INC. (UNITED STATES)
8.9 ASCENSIA DIABETES CARE (SWITZERLAND)
8.10 A. MENARINI DIAGNOSTICS (ITALY)
8.11 GLUCORX (UNITED KINGDOM)
8.12 OTHER ACTIVE PLAYERS
Chapter 9: Global Glucose Biosensor Market By Region
9.1 Overview
9.2. North America Glucose Biosensor Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product Type
9.2.4.1 Invasive Glucose Biosensors
9.2.4.2 Non-invasive Glucose Biosensors
9.2.5 Historic and Forecasted Market Size By Technology
9.2.5.1 Electrochemical Biosensors
9.2.5.2 Optical Biosensors
9.2.5.3 Thermal Biosensors
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Diabetes Management
9.2.6.2 Clinical Diagnostics
9.2.6.3 Drug Development
9.2.6.4 Others
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals and Clinics
9.2.7.2 Homecare
9.2.7.3 Research Laboratories
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Glucose Biosensor Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product Type
9.3.4.1 Invasive Glucose Biosensors
9.3.4.2 Non-invasive Glucose Biosensors
9.3.5 Historic and Forecasted Market Size By Technology
9.3.5.1 Electrochemical Biosensors
9.3.5.2 Optical Biosensors
9.3.5.3 Thermal Biosensors
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Diabetes Management
9.3.6.2 Clinical Diagnostics
9.3.6.3 Drug Development
9.3.6.4 Others
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals and Clinics
9.3.7.2 Homecare
9.3.7.3 Research Laboratories
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Glucose Biosensor Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product Type
9.4.4.1 Invasive Glucose Biosensors
9.4.4.2 Non-invasive Glucose Biosensors
9.4.5 Historic and Forecasted Market Size By Technology
9.4.5.1 Electrochemical Biosensors
9.4.5.2 Optical Biosensors
9.4.5.3 Thermal Biosensors
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Diabetes Management
9.4.6.2 Clinical Diagnostics
9.4.6.3 Drug Development
9.4.6.4 Others
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals and Clinics
9.4.7.2 Homecare
9.4.7.3 Research Laboratories
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Glucose Biosensor Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product Type
9.5.4.1 Invasive Glucose Biosensors
9.5.4.2 Non-invasive Glucose Biosensors
9.5.5 Historic and Forecasted Market Size By Technology
9.5.5.1 Electrochemical Biosensors
9.5.5.2 Optical Biosensors
9.5.5.3 Thermal Biosensors
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Diabetes Management
9.5.6.2 Clinical Diagnostics
9.5.6.3 Drug Development
9.5.6.4 Others
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals and Clinics
9.5.7.2 Homecare
9.5.7.3 Research Laboratories
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Glucose Biosensor Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product Type
9.6.4.1 Invasive Glucose Biosensors
9.6.4.2 Non-invasive Glucose Biosensors
9.6.5 Historic and Forecasted Market Size By Technology
9.6.5.1 Electrochemical Biosensors
9.6.5.2 Optical Biosensors
9.6.5.3 Thermal Biosensors
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Diabetes Management
9.6.6.2 Clinical Diagnostics
9.6.6.3 Drug Development
9.6.6.4 Others
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals and Clinics
9.6.7.2 Homecare
9.6.7.3 Research Laboratories
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Glucose Biosensor Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product Type
9.7.4.1 Invasive Glucose Biosensors
9.7.4.2 Non-invasive Glucose Biosensors
9.7.5 Historic and Forecasted Market Size By Technology
9.7.5.1 Electrochemical Biosensors
9.7.5.2 Optical Biosensors
9.7.5.3 Thermal Biosensors
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Diabetes Management
9.7.6.2 Clinical Diagnostics
9.7.6.3 Drug Development
9.7.6.4 Others
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals and Clinics
9.7.7.2 Homecare
9.7.7.3 Research Laboratories
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Glucose Biosensor Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 12.11 Billion |
|
Forecast Period 2024-32 CAGR: |
7.50 % |
Market Size in 2032: |
USD 23.21 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
Technology |
|
||
|
By Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
